| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 6 | 12 | 9 | 14 | 21 | 14 | 52 | 61 | 31 | 40 | 111 | 113 | 135 |
| Expenses | 10 | 17 | 13 | 17 | 23 | 22 | 48 | 59 | 38 | 49 | 119 | 128 | 143 |
| EBITDA | -4 | -4 | -4 | -3 | -2 | -8 | 4 | 2 | -7 | -10 | -9 | -15 | -8 |
| Operating Profit % | -66 % | -34 % | -59 % | -31 % | -10 % | -57 % | 7 % | 2 % | -23 % | -24 % | -9 % | -14 % | -11 % |
| Depreciation | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 1 | 2 | 2 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 5 | 7 |
| Profit Before Tax | -7 | -6 | -6 | -5 | -4 | -6 | 3 | -1 | -11 | -14 | -12 | -22 | -17 |
| Tax | -1 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | -10 | -2 | 0 | 0 |
| Net Profit | -6 | -6 | -6 | -5 | -3 | -6 | 3 | -1 | -12 | -4 | -10 | -22 | -14 |
| EPS in ₹ | -5.99 | -5.39 | -5.69 | -4.44 | -3.19 | -5.67 | 2.87 | -0.48 | -8.15 | -1.09 | -2.69 | -4.75 | -3.70 |
Oxygenta Pharmaceutical
Oxygenta Pharmaceutical
50.49
+0.43
(0.86%)
Market Cap
186.69 Cr
PE Ratio
-13.64
Volume
4,254.00
Day High - Low
51.75 - 49.99
52W High-Low
109.00 - 43.00
Key Fundamentals
Market Cap
186.69 Cr
EPS
-4.75
PE Ratio
-13.64
PB Ratio
-4.34
Book Value
-11.54
EBITDA
-15.37
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
38.69
Debt to Equity
0.00
Actual
Company News
View All News
Oxygenta Pharma AGM Book Closure Dates
4 days ago
4 days agoOxygenta Pharmaceutical Ltd sets book closure from Aug 15 to Aug 21, 2026, for its 33rd AGM. Remote e-voting cut-off is fixed at Aug 14, 2026.
Oxygenta Pharmaceutical Limited schedules its 33rd AGM for Aug 21, 2026. Key agenda items include approving material related party transactions with holding company Virupaksha Organics Limited and appointing new directors.
Oxygenta Pharmaceutical Ltd reported a Q1FY27 net loss of ₹2.10 crore, down from ₹6.11 crore YoY, while revenue jumped 144% to ₹37 crore.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,963.50 | #1 4,71,109.42 | 39.39 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 57.67 | |
8,585.00 | 2,27,904.78 | 83.29 | 11,067.00 | 13.95 | 2,568 | 65.50 | 87.46 | |
5,050.00 | 1,92,085.77 | 90.03 | 13,886.20 | 20.34 | 2,138 | 3.28 | 59.47 | |
1,474.40 | 1,19,108.71 | 35.46 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.69 | |
1,121.00 | 1,12,798.83 | 21.93 | 27,657.90 | 17.64 | 5,026 | 7.82 | 50.99 | |
2,393.00 | 1,09,415.75 | #1 20.61 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 46.72 | |
2,483.00 | 1,02,546.90 | 49.34 | 14,636.40 | 14.85 | 1,938 | 29.13 | 46.36 | |
1,180.00 | 98,490.95 | 30.09 | 35,058.60 | 3.90 | 4,158 | -69.10 | 39.90 | |
1,811.40 | 97,789.62 | 90.00 | 6,867.80 | 22.01 | 890 | #1 123.93 | 80.59 | |
1,554.70 | 89,454.00 | 26.19 | 33,384.70 | 3.21 | 3,376 | 1.99 | 51.68 |
Growth Rate
Revenue Growth
2.15 %
Net Income Growth
128.66 %
Cash Flow Change
119.92 %
ROE
123.77 %
ROCE
-1,067.23 %
EBITDA Margin (Avg.)
73.75 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 18 | 20 | 19 | 17 | 21 | 19 | 34 | 31 | 54 | 63 | 83 | 120 |
| Fixed Assets | 12 | 13 | 12 | 12 | 12 | 11 | 16 | 20 | 28 | 29 | 40 | 48 |
| Current Assets | 5 | 5 | 6 | 4 | 9 | 7 | 16 | 10 | 25 | 24 | 31 | 51 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 |
| Other Assets | 7 | 7 | 6 | 5 | 9 | 7 | 17 | 11 | 26 | 34 | 44 | 0 |
| Total Equity & Liabilities | 18 | 20 | 19 | 17 | 21 | 19 | 34 | 31 | 54 | 63 | 83 | 120 |
| Current Liabilities | 16 | 21 | 17 | 20 | 18 | 17 | 18 | 8 | 33 | 34 | 86 | 86 |
| Non Current Liabilities | 19 | 21 | 29 | 29 | 38 | 43 | 54 | 58 | 68 | 50 | 23 | 76 |
| Total Equity | -16 | -22 | -27 | -32 | -35 | -41 | -38 | -35 | -46 | -20 | -25 | -43 |
| Reserve & Surplus | -26 | -32 | -38 | -42 | -45 | -51 | -48 | -49 | -60 | -54 | -62 | -80 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 14 | 14 | 34 | 37 | 37 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Investing Activities | 1 | -2 | -1 | -0 | -1 | -1 | -7 | -5 | -10 | -4 | -11 |
| Operating Activities | -4 | 1 | 1 | 1 | -8 | -3 | -2 | -2 | -2 | -13 | 3 |
| Financing Activities | 3 | 1 | 0 | -1 | 8 | 3 | 9 | 6 | 11 | 17 | 9 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 17.17 % | 17.17 % | 12.33 % | 12.33 % | 12.33 % | 12.33 % | 12.33 % | 12.33 % | 8.99 % | 26.80 % | 29.73 % | 29.73 % | 29.73 % | 33.69 % | 53.28 % | 51.12 % | 51.12 % | 57.95 % | 57.95 % | 55.93 % | 56.54 % | 56.54 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.10 % | 0.10 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.07 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 65.52 % | 65.56 % | 50.63 % | 50.58 % | 50.69 % | 50.70 % | 50.72 % | 50.71 % | 52.89 % | 57.05 % | 53.65 % | 53.17 % | 53.31 % | 50.30 % | 41.81 % | 43.93 % | 43.93 % | 36.61 % | 36.55 % | 38.90 % | 38.12 % | 38.16 % |
| Others | 17.22 % | 17.18 % | 36.96 % | 37.02 % | 36.91 % | 36.89 % | 36.88 % | 36.89 % | 38.05 % | 16.13 % | 16.60 % | 17.08 % | 16.94 % | 15.98 % | 4.89 % | 4.93 % | 4.93 % | 5.41 % | 5.47 % | 5.14 % | 5.32 % | 5.27 % |
| No of Share Holders | 8,762 | 8,762 | 8,755 | 8,873 | 9,038 | 9,004 | 9,000 | 9,101 | 8,995 | 8,987 | 8,972 | 9,051 | 10,102 | 9,975 | 10,154 | 10,111 | 10,030 | 10,094 | 10,179 | 10,215 | 10,205 | 10,196 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Aug 2026 |  Annual General Meeting | NA | 21 Aug 2026 | 50.91 | 50.06 |
| 06 Dec 2021 |  Change Of Name | NA | 06 Dec 2021 | 33.70 | 33.70 |
| 09 May 2024 |  Extraordinary General Meeting | NA | 09 May 2024 | 34.14 | 37.00 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 44.77 | 63.33 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 92.50 | 83.63 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 90.99 | 87.70 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 92.49 | 91.04 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 98.00 | 90.00 |
| 19 Sept 2025 | Annual General Meeting | NA | 19 Sept 2025 | 80.55 | 71.00 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 63.68 | 66.84 |
| 04 Feb 2026 | Quarterly Result Announcement | NA | 04 Feb 2026 | 59.90 | 61.11 |
| 23 May 2026 | Quarterly Result Announcement | NA | 23 May 2026 | 54.20 | 52.60 |
| 27 Jul 2026 | Quarterly Result Announcement | NA | 27 Jul 2026 | 48.90 | 50.91 |
Announcements
Newspaper Advertisement3 days ago
3 days agoIntimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.4 days ago
4 days agoReg. 34 (1) Annual Report.4 days ago
4 days agoSubmission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Change in Management7 days ago
7 days agoUn-Audited Results For The Quarter Ended 30.06.2026.7 days ago
7 days agoBoard Meeting Outcome for Outcome For The Board Meeting Held On 27.07.20267 days ago
7 days agoUpdate on board meeting10 days ago
10 days agoBoard Meeting Intimation for The Meeting To Be Held On Saturday 25Th Day Of July 2026Jul 22, 2026
Jul 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Jul 14, 2026Closure of Trading WindowJun 24, 2026
Jun 24, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 23, 2026
May 23, 2026Audited Financial Results For The Quarter And Year Ended 31.03.2026.May 23, 2026
May 23, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2026May 23, 2026
May 23, 2026Board Meeting Intimation for The Meeting To Be Held On Saturday 23Rd May 2026.May 19, 2026
May 19, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 27, 2026
Apr 27, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 27, 2026
Apr 27, 2026Compliance As Per Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended 31St March 2026Apr 15, 2026
Apr 15, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2026
Feb 20, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 14, 2026
Feb 14, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 13, 2026
Feb 13, 2026Un-Audited Results For The Quarter And Nine Months Ended 31.12.2025.Feb 04, 2026
Feb 04, 2026Board Meeting Outcome for Outcome Of Board Meeting Dated 04.02.2026.Feb 04, 2026
Feb 04, 2026Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter Ended December 31 2025.
2. Limited Review Report For The Quarter Ended December 31 2025.
3. Any Other Business With The Permission Of The Chair.Jan 30, 2026
Jan 30, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 17, 2025
Dec 17, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 17, 2025
Dec 17, 2025Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations) To Stock Exchanges Regarding Approval Of The Shareholders For Reclassification Of Person(S) Forming Part Of ThDec 11, 2025
Dec 11, 2025Minutes Of The Resolutions Passed By Way Of Postal BallotDec 11, 2025
Dec 11, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 11, 2025
Dec 11, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 11, 2025
Dec 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Nov 12, 2025Intimation Of Calendar Of Events For The Postal Ballot Process Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 11, 2025
Nov 11, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 07, 2025
Nov 07, 2025Un Audited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 07, 2025
Nov 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.11.2025Nov 07, 2025
Nov 07, 2025Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025.
2. Limited Review Report For The Quarter Ended September 30 2025.
3. Any Other Business With The Permission Of The Chair.Nov 03, 2025
Nov 03, 2025Disclosure Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Oct 22, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2025
Oct 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 18, 2025
Oct 18, 2025Announcement Under Regulation 30Oct 16, 2025
Oct 16, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Sep 19, 2025Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The Promoter / Promoter Group From Promoter Group Category To Public Category Shareholder Of The Company Pursuant To Regulation 31A Of Securities And Exchange Board Of Aug 29, 2025
Aug 29, 2025Intimation Of Book Closure And Cut-Off Date For The 32Nd Annual General Meeting Of Oxygenta Pharmaceutical LimitedAug 28, 2025
Aug 28, 2025Technical Indicators
RSI(14)
Neutral 52.07
ATR(14)
Less Volatile 2.81
STOCH(9,6)
Neutral 42.39
STOCH RSI(14)
Oversold 18.21
MACD(12,26)
Bullish 0.12
ADX(14)
Weak Trend 17.55
UO(9)
Bearish 38.57
ROC(12)
Uptrend And Accelerating 1.79
WillR(14)
Neutral -57.74
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
